U.S. Transportation Stock News

NYSE:FUL
NYSE:FULChemicals

H.B. Fuller (FUL) Stock Sees Margin Improvement That Tests Bearish Leverage Narrative

H.B. Fuller (FUL) has just posted Q2 2026 results with revenue of US$950.3 million, Basic EPS of US$1.25 and net income excluding extra items of US$67.8 million, giving investors a clear look at how the business is performing at mid year. The company has seen quarterly revenue move from US$898.1 million in Q2 2025 to US$950.3 million in Q2 2026, while Basic EPS shifted from US$0.77 to US$1.25 over the same period. This sets the stage for investors to focus on how these results feed through to...
NYSE:PII
NYSE:PIILeisure

Polaris (PII) Secures Permanent Outdoor Grants Funding And Adds Dustin Semach To Board

Polaris (NYSE:PII) has secured long-term funding dedicated to outdoor recreation initiatives across America's National Forests. The company announced that its Polaris Fund for Outdoor Recreation Grants is now fully endowed, providing ongoing support for conservation, access, and stewardship projects. Polaris also appointed Dustin J. Semach to its Board of Directors, adding industry and financial experience at an important moment for its governance. Polaris, known for its off-road vehicles,...
NYSE:VNO
NYSE:VNOOffice REITs

Vornado Realty Trust (VNO) Stock After Mixed Returns And Office Market Uncertainty

If you are trying to work out whether Vornado Realty Trust at around US$38 per share looks expensive or appealing, the key question is how its current price stacks up against a fair value estimate. The stock has recent returns of 0.7% over 7 days, 16.5% over 30 days, 13.8% year to date, 4.8% over 1 year, a very large gain over 3 years and a 5.0% decline over 5 years, which gives a mixed picture of momentum and risk. Recent news around office real estate, including ongoing debate about long...
NasdaqGM:SPRY
NasdaqGM:SPRYBiotechs

How Does ARS Pharmaceuticals' (SPRY) Neffy Coverage Stall Reframe Its Path to Cash-Flow Break-Even?

Earlier this week, ARS Pharmaceuticals reported that neffy, its epinephrine nasal spray, did not gain any new major commercial insurance coverage in the July 1, 2026 review cycle, though the company did secure additional Medicaid coverage and reduced its planned 2026 cash-based operating expenses. The update also included management’s reaffirmation that the existing neffy business underpins a path to cash-flow break-even in 2027, underscoring how payer access remains central to the company’s...
NYSE:HSY
NYSE:HSYFood

Hershey (HSY) Appoints PepsiCo Veteran Heather Hoytink To Lead Its U.S. Business

Hershey (NYSE:HSY) has appointed Heather Hoytink as President, U.S. Hoytink joins Hershey after a high-profile sales and commercial leadership career at PepsiCo. The appointment puts a new leader in charge of Hershey’s core U.S. business, which drives a large share of its revenue and product activity. For investors tracking Hershey at a share price of $176.68, this leadership change lands at a time when the stock has delivered mixed returns. HSY is up 2.3% over the past week and 9.0% over...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Starlink Mobile Pressure Puts These US Telecom Stocks In Focus

SpaceX’s plan to roll out a Starlink mobile service in the US puts fresh pressure on established telecom stocks, as a new competitor steps directly into the multibillion dollar phone network market. For investors, the story is less about rockets and more about how capital heavy network buildouts, spectrum needs, and changing consumer options could reshape parts of the US telecommunications sector. This article breaks down 3 stocks from our sector screener that are closely exposed to this...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Rushed Health Net Support To Members After The LA County Fire Emergency

Health Net, a Centene Corporation (NYSE:CNC) subsidiary, is mobilizing support for members and providers following the State of Emergency in Los Angeles County. The company is suspending prescription refill limits and waiving prior authorization requirements for affected members. These measures are intended to help maintain access to care and medication during the LA County fire emergency. Centene operates as a major managed care provider in government sponsored healthcare programs, so...
NYSE:CALX
NYSE:CALXCommunications

Corning Stock Rally Points To 3 US Optical Connectivity Stocks To Watch

Corning’s rally and the surge of interest around optical connectivity have thrown a spotlight on a corner of U.S. advanced manufacturing that many investors rarely look at closely. Long term supply agreements tied to data centers, AI related workloads, and high capacity communications can reshape how certain companies earn and plan future cash flows. This article looks at 3 stocks that appear positively exposed to the same themes moving Corning, using our U.S. Advanced Manufacturing screener...
NYSE:NIO
NYSE:NIOAuto

NIO (NIO) Launches Five Seat ES8 As F2 Factory Wins Global Lighthouse Status

NIO plans to launch a new five seat ES8 variant, adding to its existing ES8 SUV line in the premium electric SUV segment. The company’s F2 factory has been recognized as a World Economic Forum Global Lighthouse for advanced intelligent manufacturing. These updates combine a broader product lineup with third party recognition of NIO’s smart EV production capabilities. NIO (NYSE:NIO) is drawing attention with both a new product variant and a manufacturing milestone, while its stock trades at...
NYSE:LOW
NYSE:LOWSpecialty Retail

Lowe's (LOW) Launches Creator Program To Turn Product Ideas Into Store Shelves

Lowe's Companies (NYSE:LOW) launched its "Creator: Into the Blue" program, expanding its creator efforts beyond content into product development. The program invites creators to pitch new or existing product ideas that could potentially reach Lowe's store shelves. Participants may gain access to Lowe's design, development, and distribution resources as part of the initiative. Lowe's Companies operates as a major home improvement retailer, serving both DIY customers and professional...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

MillerKnoll (MLKN) Stock Faces Narratives Test As Profitability Returns After Prior Losses

MillerKnoll (MLKN) has reported its FY 2026 results with fourth quarter revenue of US$1,004.2 million and basic EPS of US$0.34, supported by trailing twelve month revenue of US$3.8 billion and EPS of US$1.33. Over recent periods, the company has seen quarterly revenue move from US$876.2 million in FY 2025 Q3 to US$1,004.2 million in FY 2026 Q4, while quarterly EPS has ranged from a loss of US$0.84 in FY 2025 Q4 to a profit of US$0.34 in FY 2026 Q4. This provides a basis for investors to focus...
NYSE:B
NYSE:BMetals and Mining

Barrick Mining (NYSE:B) Stock Is Back In Focus After An Earnings Beat

Barrick Mining (NYSE:B) is being viewed as a potential safe-haven gold stock as geopolitical tensions and gold prices rise. The company recently reported earnings that surpassed analyst expectations, drawing fresh attention from investors. Stronger results and heightened interest in gold as a defensive asset are supporting renewed focus on Barrick shares. Barrick Mining, one of the largest global gold producers, is back in focus as investors look for ways to add defensive exposure to...
NasdaqGS:AZTA
NasdaqGS:AZTALife Sciences

3 Promising Undervalued Small Caps With Insider Action In June 2026

Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up by 19% over the past year with earnings projected to grow by 18% annually. In this dynamic environment, identifying promising small-cap stocks that are perceived as undervalued and exhibit insider activity can offer intriguing opportunities for investors seeking potential growth.
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

High Growth Tech Stocks In US For June 2026

Over the last 7 days, the United States market has dropped 2.7%, yet it remains up by 19% over the past year, with earnings forecasted to grow by 18% annually. In this environment, identifying high growth tech stocks involves looking for companies that not only show strong potential for revenue growth but also demonstrate resilience and adaptability in fluctuating market conditions.
NYSE:EQBK
NYSE:EQBKBanks

3 High Growth Companies Insiders Are Banking On

Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up by 19% over the past year with earnings projected to grow by 18% annually. In this fluctuating environment, companies that exhibit high growth potential and significant insider ownership can be particularly appealing as they often signal confidence from those who know the business best.
NasdaqCM:YIBO
NasdaqCM:YIBOCommercial Services

June 2026 Promising Penny Stocks To Watch

Over the last 7 days, the United States market has dropped 2.7%, yet it has risen by 19% over the past year, with earnings forecasted to grow annually by 18%. For investors exploring smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value when backed by solid financial foundations. This article highlights several penny stocks that demonstrate financial strength and potential for long-term growth amid current market conditions.
NasdaqGS:COLB
NasdaqGS:COLBBanks

Is Columbia Banking System (COLB) A Bargain After Earnings And Its Business Barometer Update?

Early market reaction to Columbia Banking System earnings and sentiment update Columbia Banking System (COLB) has been in focus after a mixed quarterly report, where earnings per share exceeded expectations, revenue aligned with forecasts, and tangible book value per share slightly missed, alongside a separate Business Barometer sentiment release. See our latest analysis for Columbia Banking System. At a share price of US$32.07, Columbia Banking System has seen firm momentum, with a 20.11% 90...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

PTC Therapeutics (PTCT) Launches Sephience After Strong Early Sales And $500 Million Raise

PTC Therapeutics (NasdaqGS:PTCT) has launched Sephience, its newly approved treatment for phenylketonuria, with early sales described as strong. The company has completed a US$500 million convertible note offering to support future business development activity. PTC Therapeutics is also working within an ongoing collaboration with Novartis that frames a broader period of change for the business. For investors following rare disease drug developers, PTC Therapeutics sits at an interesting...